Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Rachel Howard
  • October 6, 2017
  • Articles

Deep Dive - MINT: opportunities in ‘frontier’ markets?

Deep Dive - MINT: opportunities in ‘frontier’ markets?

Published in Pharmaphorum’s Deep Dive magazine October 2017

According to British economist Jim O’Neill, MINT is the new BRIC. What is MINT? An acronym he coined for the ‘frontier’ markets of Mexico, Indonesia, Nigeria and Turkey. These are the countries he believes are poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them. What are the prospects for pharma in MINT? Research Partnership’s Rachel Howard and Sue Rees investigate the pros and cons.

read more »

Interactive infographic: LATAM

Interactive infographic: LATAM

An overview of the six most-commonly researched, largest pharma markets in Latin America

The LATAM region's largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With pharmaceutical sales of more than $64bn, it is an attractive market for pharma, however it is also one in which each market differs in terms of opportunities and challenges. 

read more »

  • Posted by Rachel Howard
  • July 7, 2014
  • Articles

Exploring MINT: Part 1 - Mexico

Exploring MINT: Part 1 - Mexico

Published in eyeforpharma 7 July 2014 by Rachel Howard

Buzz about Brazil (the ‘B’ in the ‘BRIC’ wave of emerging markets) has typically overshadowed the potential of Mexico, the second-largest pharmaceutical market in Latin America. However, recent years have seen significant changes to the Mexican healthcare system and regulations, which have led to pharma finally starting to sit up and take notice of the potential Mexico has to offer. 

read more »